Laboratory Products
Innovative Live Cell Imaging and Analysis Platform Availability Grows
Mar 22 2010
Chip-Man Technologies’ innovative Cell-IQ live cell imaging and analysis platform is now available to academic and industrial research laboratories in Switzerland through LabForce AG, supplier of cell and molecular biology reagents and instruments. Chip-Man Technologies’ unique system is a powerful tool for researchers wishing to study cell lines, primary cell, cocultures and mono-layer tissue models.
The Cell-IQ system allows scientists to study live cell behaviour in an optimised and stable environment and automatically analyses the findings, supporting the research efforts of scientists in areas such as cell biology,
functional genomics, drug discovery, in vitro fertilisation, in vitro toxicology and regenerative medicine. The Cell-IQ is accompanied by easy-to-use software, and is capable of many different investigations, such as the continuous observation of cells and automated recognition of dead and live cells, which can be particularly useful for the rapid determination of the IC50 of compounds.
Dr Christiane Klas, CEO and cofounder of LabForce, said: “We are very excited to be working with Chip-Man Technologies and supplying its automated cellular research solutions in Switzerland. There are many researchers from universities, research hospitals, pharmaceutical and biotechnology companies in Switzerland who are already very interested in the Cell-IQ platform, because it is so versatile and capable of performing a range of investigations that would otherwise require several different instruments.”
Digital Edition
Lab Asia 31.2 April 2024
April 2024
In This Edition Chromatography Articles - Approaches to troubleshooting an SPE method for the analysis of oligonucleotides (pt i) - High-precision liquid flow processes demand full fluidic c...
View all digital editions
Events
May 21 2024 Lagos, Nigeria
May 22 2024 Basel, Switzerland
Scientific Laboratory Show & Conference 2024
May 22 2024 Nottingham, UK
May 23 2024 Beijing, China
May 28 2024 Tel Aviv, Israel